#MormonInChief, By Brigham Young Graduate Matthew Greene, to Play FringeNYC; Casting Announced | Playbill

Related Articles
News #MormonInChief, By Brigham Young Graduate Matthew Greene, to Play FringeNYC; Casting Announced Jesse Liebman, Nicole Rodenburg and Karis Danish will star in the FringeNYC world premiere of #MormonInChief, a new play by Brigham Young University graduate Matthew Greene, which will debut Aug. 11 at the Kraine Theater.

Austin Regan will direct the limited run that will play Aug. 11, 14, 18, 19 and 22 at the Kraine. Regan was the associate director of Broadway's On a Clear Day…, American Idiot and Everyday Rapture. Michael Holt produces the 90-minute play.

Here's how #MormonInChief is billed: "One tweet. Unimaginable consequences. Unassuming Mormon, Connor Jorgensen, becomes the center of national media frenzy when his tweets about a Mormon presidential candidate go viral. Inspired by comments the candidate allegedly made in a church meeting, Connor spreads his presidential pick's views on 'the gays, illegals and bleeding hearts,' leading ambitious reporter Lydia Strout to his door. As Lydia tries to find the man hiding behind the orthodox Mormon facade, and Connor navigates the unfamiliar world of Tweets, news feeds, and blogs, both are forced to confront the choice between living by facts or walking by faith."

Liebman ("Did You Hear About the Morgans?," "The Girl's Guide to Depravity") Rodenburg (The Whale, The End) and Danish (Doubt) comprise the three-actor cast.

The production will have scenic design by Jason Ardizzone-West, projections/lighting design by David Bengali and costume design by Beth Goldenberg.

Greene's plays also include Adam and Steve and the Empty Sea, Job Well Done, Bread of Affliction and Man to Man. Tickets, priced $15-$18, are available by visiting FringeNYC.org. The Kraine Theater is located at 85 West 4th Street.

Today’s Most Popular News:

Blocking belongs
on the stage,
not on websites.

Our website is made possible by
displaying online advertisements to our visitors.

Please consider supporting us by
whitelisting playbill.com with your ad blocker.
Thank you!